Renal outcomes and all‐cause death associated with sodium‐glucose co‐transporter‐2 inhibitors versus other glucose‐lowering drugs (CVD‐REAL 3 Korea)

AIMS: To investigate the effectiveness of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors on the risk of progression to end‐stage renal disease (ESRD) and all‐cause mortality in a broad range of patients with type 2 diabetes (T2D) using a Korean nationwide cohort. MATERIALS AND METHODS: Using dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Eun Sil, Han, Kyungdo, Nam, You‐Seon, Wittbrodt, Eric T., Fenici, Peter, Kosiborod, Mikhail N., Heerspink, Hiddo J. L., Yoo, Soon‐Jib, Kwon, Hyuk‐Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839503/
https://www.ncbi.nlm.nih.gov/pubmed/33118320
http://dx.doi.org/10.1111/dom.14239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839503/
https://www.ncbi.nlm.nih.gov/pubmed/33118320
http://dx.doi.org/10.1111/dom.14239

Ejemplares similares